|
CHRONOLOGY OF EVENTS LEADING TO MULTIPLE COUNTS OF CRIMINAL ANIMAL
CRUELTY FILED AGAINST THE NIH'S "ALAMOGORDO PRIMATE FACILITY"
OPERATOR
Prepared by In Defense of Animals /
September 7th, 2004
1
| 2 | 3
| 4 | 5
| 6 | 7
| 8 | 9 | 10
| 11 | 12
| 13 | 14
| 15 | 16
| 17 | 18
| 19 | 20
8 
June 22, 2000 - In response to a federal lawsuit filed by IDA to obtain Coulston-related records under the Freedom of Information Act, USDA Western Regional Director Dr. Robert Gibbens states in a sworn affidavit
(Gibbens Affidavit) that the USDA anticipates filing charges against the Coulston lab for violations the agency uncovered regarding the gruesome November 1999 death of Donna. The USDA will not file charges against the Coulston lab until July 2001, almost two years after Donna's death. Sources tell IDA that the USDA delays its filing at the request of the NIH. The July 2001 USDA charges will come one month after the NIH stops all funding of The Coulston Foundation.
August 2000 - Ray, one of the 288 chimpanzees taken over by the NIH, dies at the Foundation after being left untreated for Coccidioidomycosis (also known as Valley Fever), which is endemic in New Mexico. IDA's network of whistleblowers states that the Coulston Foundation veterinarian who failed to treat Ray is Dr. Paul Langner.
October 2000 - The NIH rejects The Coulston Foundation's bid for a contract to take over the care of the 288 NIH-"owned" chimpanzees. The agency revises its bid guidelines; perhaps most importantly, the revised bid states that the Air Force has decreed that no research can be conducted on Holloman Air Force Base. Two new candidates hoping to take over emerge: Priority One Services, a Maryland-based services company, and Charles River Laboratories, Inc., a multinational conglomerate that is the world's largest private supplier of "animal models" for experiments, owns various toxicology labs, has advertised the availability of chimpanzees for toxicology testing, and is by far the largest importer of nonhuman primates into the United States.
December 2000 - The FDA re-inspects The Coulston Foundation and finds further violations of the GLP regulations, including the lab's initiation of multiple new studies despite the agency's prohibition from the December 1999 Warning Letter. The FDA findings corroborate information provided by IDA's network of whistleblowers. The NIH continues to fund the lab.
8
1
| 2 | 3
| 4 | 5
| 6 | 7
| 8 | 9 | 10
| 11 | 12
| 13 | 14
| 15 | 16
| 17 | 18
| 19 | 20
|
